Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Blankenstein

Showing results (51-60 of 138) with videos related to

Pageof 14
Sort By:
Journal for Immunotherapy of Cancer|March 14, 2023
Response to: Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Chheda <i>et al</i>Lena Immisch, George Papafotiou, Oliver Popp, et al.
Human Gene Therapy|July 8, 2005
Redirecting human T lymphocytes toward renal cell carcinoma specificity by retroviral transfer of T cell receptor genesBoris Engels, Elfriede Noessner, Bernhard Frankenberger, et al.
Blood|January 12, 2013
Differently immunogenic cancers in mice induce immature myeloid cells that suppress CTL in vitro but not in vivo following transferKarin Schmidt, Serena Zilio, Jan C Schmollinger, et al.
Oncology Reports|November 27, 2010
Immunolabelling of the inhibin/activin-βC subunit in normal and malignant human uterine cervical tissue and cervical cancer cell linesThomas Blankenstein, Julia Jückstock, Naim Shabani, et al.
International Journal of Cancer|March 25, 2010
Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosisDana Briesemeister, Daniel Sommermeyer, Christoph Loddenkemper, et al.
Cancer Research|July 23, 2003
A critical requirement of interferon gamma-mediated angiostasis for tumor rejection by CD8+ T cellsZhihai Qin, Johannes Schwartzkopff, Felicia Pradera, et al.
BMC Medical Genomics|November 29, 2019
Identification and ranking of recurrent neo-epitopes in cancerEric Blanc, Manuel Holtgrewe, Arunraj Dhamodaran, et al.
Nature Communications|July 2, 2025
Mice with a diverse human T cell receptor repertoire selected on multiple HLA class I moleculesArunraj Dhamodaran, Xiaojing Chen, Niklas Fellmer, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 9, 2011
Immunolabeling of the inhibin-βA and -βB subunit in normal and malignant human cervical tissue and cervical cancer cell linesJulia Jückstock, Ansgar Brüning, Thomas Blankenstein, et al.
Blood|May 27, 2011
The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processedJelena Popovic, Liang-Ping Li, Peter Michael Kloetzel, et al.
Pageof 14

Showing results (51-60 of 138) with videos related to

Sort By:
Pageof 14
Journal for Immunotherapy of Cancer|March 14, 2023
Response to: Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Chheda <i>et al</i>Lena Immisch, George Papafotiou, Oliver Popp, et al.
Human Gene Therapy|July 8, 2005
Redirecting human T lymphocytes toward renal cell carcinoma specificity by retroviral transfer of T cell receptor genesBoris Engels, Elfriede Noessner, Bernhard Frankenberger, et al.
Blood|January 12, 2013
Differently immunogenic cancers in mice induce immature myeloid cells that suppress CTL in vitro but not in vivo following transferKarin Schmidt, Serena Zilio, Jan C Schmollinger, et al.
Oncology Reports|November 27, 2010
Immunolabelling of the inhibin/activin-βC subunit in normal and malignant human uterine cervical tissue and cervical cancer cell linesThomas Blankenstein, Julia Jückstock, Naim Shabani, et al.
International Journal of Cancer|March 25, 2010
Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosisDana Briesemeister, Daniel Sommermeyer, Christoph Loddenkemper, et al.
Cancer Research|July 23, 2003
A critical requirement of interferon gamma-mediated angiostasis for tumor rejection by CD8+ T cellsZhihai Qin, Johannes Schwartzkopff, Felicia Pradera, et al.
BMC Medical Genomics|November 29, 2019
Identification and ranking of recurrent neo-epitopes in cancerEric Blanc, Manuel Holtgrewe, Arunraj Dhamodaran, et al.
Nature Communications|July 2, 2025
Mice with a diverse human T cell receptor repertoire selected on multiple HLA class I moleculesArunraj Dhamodaran, Xiaojing Chen, Niklas Fellmer, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 9, 2011
Immunolabeling of the inhibin-βA and -βB subunit in normal and malignant human cervical tissue and cervical cancer cell linesJulia Jückstock, Ansgar Brüning, Thomas Blankenstein, et al.
Blood|May 27, 2011
The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processedJelena Popovic, Liang-Ping Li, Peter Michael Kloetzel, et al.
Pageof 14